Table 3 Significant correlations between chromosome aberrations, side effects, and RILA values over time.
Before therapy | Directly after therapy | 3 months | 6 months | 9 months | 12 months | 24 months | 36 months | 48 months | 60 months | |
|---|---|---|---|---|---|---|---|---|---|---|
Acute GU side effects | chrom. br., dic., total a., ab.cell | dic. | dic. | |||||||
Acute GI side effects | chrom. br. | total a.,ab. cell, | chrom. br. | chrom. br., ab.cell | ||||||
Cumulative late GU side effects | total a., ab.cell | |||||||||
Cumulative late GI side effects | ||||||||||
Acute IPSS score | dic., total a., ab.cell | |||||||||
Acute QoL score | chrom. br. | dic., total a., ab.cell | ||||||||
Late cumulative IPSS increase | chrom. br. | |||||||||
Late cumulative QoL increase | total a. | |||||||||
Late cumulative IPSS score | chrom. br., total a., ab.cell | chrom. br., total a. | chrom. br. | dic., ab.cell | dic. | total a., ab.cell | ||||
Late cumulative QoL score | chrom. br., total a. | dic. | ||||||||
RILA value (%) | chrom. br. | chrom. br. |
